Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis?
Authors:
- Krystyna PawlakKPKrystyna Pawlak
- Blanka UlazkaBUBlanka Ulazka
- Michal MysliwiecMMMichal Mysliwiec
- Dariusz PawlakDariusz Pawlak
- 1 November 2012
- journal article
- Published by Elsevier in Translational Research
- Vol. 160 (5) , 346-354
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosisBMC Nephrology, 2011
- Chronic kidney disease: a public health priority and harbinger of premature cardiovascular diseaseJournal of Internal Medicine, 2010
- Hyperfibrinolysis, uPA/suPAR System, Kynurenines, and the Prevalence of Cardiovascular Disease in Patients With Chronic Renal Failure on Conservative TreatmentThe American Journal of the Medical Sciences, 2010
- Inactivation of uPA and its receptor uPAR by 3,3′‐diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migrationJournal of Cellular Biochemistry, 2009
- Atherosclerotic plaque development and instability: A dual role for VEGFAnnals of Medicine, 2009
- Tissue Factor, Tissue Factor Pathway Inhibitor and Vascular Endothelial Growth Factor-A in Carotid Atherosclerotic PlaquesEuropean Journal of Vascular and Endovascular Surgery, 2005
- Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejectionKidney International, 2003
- Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?Clinical Science, 2003
- Editorial boardAmerican Journal of Kidney Diseases, 2002
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsBiochemical and Biophysical Research Communications, 1991